Hugh Alexander Ilyine
Oprichter bij Profactor Pharma Ltd.
Actieve functies van Hugh Alexander Ilyine
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Profactor Pharma Ltd.
 Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Directeur/Bestuurslid | 01-01-2009 | - |
| Oprichter | 01-01-2009 | - | |
Destina Genomics Ltd.
 Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Directeur/Bestuurslid | 01-01-2011 | - |
| Algemeen Directeur | 01-01-2011 | - | |
| Oprichter | 01-01-2011 | - |
Loopbaan van Hugh Alexander Ilyine
Eerdere bekende functies van Hugh Alexander Ilyine
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Stem Cell Sciences Plc | Operationeel Directeur | - | 07-04-2009 |
| Sierra Leone Diamond Co. Ltd. | Operationeel Directeur | - | 17-08-2007 |
Statistieken
Internationaal
| Verenigd Koninkrijk | 5 |
Operationeel
| Chief Operating Officer | 2 |
| Director/Board Member | 2 |
| Founder | 2 |
Sectoraal
| Health Technology | 3 |
| Non-Energy Minerals | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
| Sierra Leone Diamond Co. Ltd. | Non-Energy Minerals |
| Stem Cell Sciences Plc | Commercial Services |
Profactor Pharma Ltd.
Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Health Technology |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
